Ibritumomab Intravenous and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Ibritumomab Intravenous and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Moxifloxacin
- Ibritumomab Intravenous-Moxifloxacin (Systemic)
- Ibritumomab Intravenous-Moxifloxacin Hydrochloride
- Ibritumomab Intravenous-Moxifloxacin Injection
- Ibritumomab Intravenous-Moxifloxacin Intravenous
- Ibritumomab Intravenous-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Ibritumomab Tiuxetan
- Moxetumomab pasudotox-tdfk Intravenous-Ibrutinib
- Moxetumomab pasudotox-tdfk Intravenous-Ibrutinib Capsules
- Moxetumomab pasudotox-tdfk Intravenous-Ibrutinib Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Ibu
- Moxetumomab pasudotox-tdfk Intravenous-IBU Tablets